Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription 16.08.2021 2 BMC Neurol 1 Brain 1 Int J Clin Pract 2 J Autoimmun 3 J Neuroimmunol 3 J Neurol 9 Mult Scler 1 Nat Rev Neurol 6 Neurology 1 PLoS Med 3 Proc Natl Acad Sci U S A 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. ASMARIAN N, Sharafi Z, Mousavi A, Jacques R, et al
   Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study.
   BMC Neurol. 2021;21:309.
   PubMed         Abstract available
   
   
2. FRITZ-WELTIN M, Frommherz E, Isenmann N, Niedermeier L, et al
   Hepatitis E virus as a trigger for Guillain-Barre syndrome.
   BMC Neurol. 2021;21:304.
   PubMed         Abstract available
   
   

   
   Brain

3. NAUGHTON M, de la Fuente AG
   Autoantibodies and microglia: boon or bane?
   Brain. 2021 Aug 11. pii: 6348165. doi: 10.1093.
   PubMed        
   
   

   
   Int J Clin Pract

4. MIRASHRAFI S, Hejazi Taghanaki SZ, Sarlak F, Moravejolahkami AR, et al
   Effect of Probiotics Supplementation on Disease Progression, Depression, General Health and Anthropometric Measurements in Relapsing-Remitting Multiple Sclerosis Patients: A Systematic Review and Meta-analysis of Clinical Trials.
   Int J Clin Pract. 2021 Aug 11:e14724. doi: 10.1111/ijcp.14724.
   PubMed         Abstract available
   
   

   
   J Autoimmun

5. HANSEN RB, Simard JF, Faurschou M, Jacobsen S, et al
   Distinct patterns of comorbidity prior to diagnosis of incident systemic lupus erythematosus in the Danish population.
   J Autoimmun. 2021;123:102692.
   PubMed         Abstract available
   
   
6. LU Q, Long H, Chow S, Hidayat S, et al
   Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
   J Autoimmun. 2021;123:102707.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

7. LOVETT-RACKE AE, Yang Y, Liu Y, Gormley M, et al
   B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report.
   J Neuroimmunol. 2021;359:577676.
   PubMed         Abstract available
   
   
8. PAGENKOPF C, Sudmeyer M
   A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.
   J Neuroimmunol. 2021;358:577606.
   PubMed         Abstract available
   
   
9. GHOSH R, Dubey S, Mandal A, Ray BK, et al
   Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis.
   J Neuroimmunol. 2021;358:577655.
   PubMed         Abstract available
   
   

   
   J Neurol

10. ANDERSEN MA, Buron MD, Magyari M
    Late-onset MS is associated with an increased rate of reaching disability milestones.
    J Neurol. 2021;268:3352-3360.
    PubMed         Abstract available
    
    
11. HOFSTADT-VAN OY U, Stankovic S, Kelbel C, Oswald D, et al
    Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19.
    J Neurol. 2021;268:3125-3128.
    PubMed         Abstract available
    
    
12. MARGONI M, Preziosa P, Filippi M, Rocca MA, et al
    Anti-CD20 therapies for multiple sclerosis: current status and future perspectives.
    J Neurol. 2021 Aug 11. pii: 10.1007/s00415-021-10744.
    PubMed         Abstract available
    
    

    
    Mult Scler

13. PANDIT L
    Fair and equitable treatment for multiple sclerosis in resource-poor regions: The need for off-label therapies and regional treatment guidelines.
    Mult Scler. 2021;27:1320-1322.
    PubMed        
    
    
14. COMI G, Dadon Y, Sasson N, Steinerman JR, et al
    CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis.
    Mult Scler. 2021 Aug 11:13524585211032803. doi: 10.1177/13524585211032803.
    PubMed         Abstract available
    
    
15. ZHENG F, Li Y, Zhuo Z, Duan Y, et al
    Structural and functional hippocampal alterations in Multiple sclerosis and neuromyelitis optica spectrum disorder.
    Mult Scler. 2021 Aug 11:13524585211032800. doi: 10.1177/13524585211032800.
    PubMed         Abstract available
    
    
16. AYADI N, Oertel FC, Asseyer S, Rust R, et al
    Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Mult Scler. 2021 Aug 11:13524585211032801. doi: 10.1177/13524585211032801.
    PubMed         Abstract available
    
    
17. DE MOL CL, Neuteboom RF, Jansen PR, White T, et al
    White matter microstructural differences in children and genetic risk for multiple sclerosis: A population-based study.
    Mult Scler. 2021 Aug 11:13524585211034826. doi: 10.1177/13524585211034826.
    PubMed         Abstract available
    
    
18. WEINSTOCK-GUTTMAN B, Bermel R, Cutter G, Freedman MS, et al
    Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial.
    Mult Scler. 2021 Aug 12:13524585211035740. doi: 10.1177/13524585211035740.
    PubMed         Abstract available
    
    
19. CLAFLIN SB, Campbell JA, Mason DF, Kalincik T, et al
    The effect of national disease-modifying therapy subsidy policy on long-term disability outcomes in people with multiple sclerosis.
    Mult Scler. 2021 Aug 13:13524585211035948. doi: 10.1177/13524585211035948.
    PubMed         Abstract available
    
    
20. MARCHESI O, Bonacchi R, Valsasina P, Preziosa P, et al
    Functional and structural MRI correlates of executive functions in multiple sclerosis.
    Mult Scler. 2021 Aug 13:13524585211033184. doi: 10.1177/13524585211033184.
    PubMed         Abstract available
    
    
21. ROMMER PS, Bsteh G, Berger T, Zettl UK, et al
    SARS-CoV-2 antibodies in multiple sclerosis patients depending on the vaccine mode of action?
    Mult Scler. 2021 Aug 13:13524585211039128. doi: 10.1177/13524585211039128.
    PubMed        
    
    

    
    Nat Rev Neurol

22. LEMPRIERE S
    Multiple sclerosis treatment blunts SARS-CoV-2 antibody response.
    Nat Rev Neurol. 2021 Aug 9. pii: 10.1038/s41582-021-00551.
    PubMed        
    
    

    
    Neurology

23. KOCH MW, Mostert J, Zhang Y, Wolinsky JS, et al
    Association of Age With Contrast-Enhancing Lesions Across the Multiple Sclerosis Disease Spectrum.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012603.
    PubMed         Abstract available
    
    
24. PETERSSON M, Feresiadou A, Jons D, Ilinca A, et al
    Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort: Cross-sectional Analysis of the Swedish GEMG Study.
    Neurology. 2021 Aug 10. pii: WNL.0000000000012604.
    PubMed         Abstract available
    
    
25. STRUPP M, Frenzel C, Goldschagg N, Halmagyi GM, et al
    Teaching Video NeuroImage: One Bedside Test, 2 Clinical Signs: One Vestibular, the Other Ocular Motor.
    Neurology. 2021;97:e541-e542.
    PubMed        
    
    
26. FREY J, Kramer J, Castellani R, Sriwastava S, et al
    Clinical Reasoning: A 47-Year-Old With Headache, Vertigo, and Double Vision.
    Neurology. 2021;97:e535-e539.
    PubMed        
    
    
27. CHEN T
    Clinical Reasoning: A 68-Year-Old Man With Proximal Weakness and Seizures.
    Neurology. 2021;97:e423-e428.
    PubMed        
    
    
28. JOLLIFFE EA, Guo Y, Hardy TA, Morris PP, et al
    Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis.
    Neurology. 2021 May 19. pii: WNL.0000000000012230.
    PubMed         Abstract available
    
    

    
    PLoS Med

29. ELSER H, Parks RM, Moghavem N, Kiang MV, et al
    Anomalously warm weather and acute care visits in patients with multiple sclerosis: A retrospective study of privately insured individuals in the US.
    PLoS Med. 2021;18:e1003580.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

30. SINGH KD, Jara ZP, Harford T, Saha PP, et al
    Novel allosteric ligands of the angiotensin receptor AT1R as autoantibody blockers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    
31. LONGBRAKE EE, Hafler DA
    (23)Na imaging: Worth its salt for understanding multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        
    
    
32. JING X, Yao Y, Wu D, Hong H, et al
    IFP35 family proteins promote neuroinflammation and multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available
    
    

    
    Thyroid

33. WAN S, Liu L, Ren B, Qu M, et al
    DNA methylation patterns in the HLA-DPB1 and PDCD1LG2 gene regions in patients with autoimmune thyroiditis from different water iodine areas.
    Thyroid. 2021 Aug 12. doi: 10.1089/thy.2021.0221.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: